5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review (Q37805539)

23 August 2017

5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review (English)

1 reference

23 August 2017

0 references

0 references

1 reference

R F Wolff

1

1 reference

23 August 2017

M M Bala

2

1 reference

23 August 2017

M Westwood

3

1 reference

23 August 2017

A G Kessels

4

1 reference

23 August 2017

J Kleijnen

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

10 October 2010

1 reference

Acta Neurologica Scandinavica

23 August 2017

1 reference

23 August 2017

123

1 reference

23 August 2017

5

1 reference

23 August 2017

295-309

1 reference

Prevalence of chronic pain with neuropathic characteristics in the general population.

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Management of herpes zoster and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Effectiveness and time to onset of pregabalin in patients with neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Topical lidocaine for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Topical lidocaine gel relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Evidence-based pharmacological treatment of neuropathic pain syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Pharmacologic treatment of pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Systematic overview of the pharmacological management of postherpetic neuralgia. An evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Treatments for postherpetic neuralgia--a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01433.X

10.1111/J.1600-0404.2010.01433.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference